Editorial: Immunological Interactions Between Host and Microbiota for Tailored Microbial Therapies, Volume II
By
Shashank Gupta
Sunil Kumar Raghav
Nar Singh Chauhan
July 7, 2026
Clinical Scorecard: Editorial: Immunological Interactions Between Host and Microbiota for Tailored Microbial Therapies, Volume II
At a Glance
Category Detail
Condition Host-microbiota immuno-interactions Key Mechanisms Microbial metabolites and structural molecules influence immune responses and maintain immune homeostasis. Target Population Individuals with dysbiosis or immune-related conditions. Care Setting Research and clinical settings focusing on personalized microbial therapeutics.
Key Highlights
Host-microbiota interactions are crucial for immune system education and disease susceptibility. Dysbiosis can lead to pathological conditions and serve as biomarkers for disease risk. Microbiome-informed approaches can enhance clinical management and disease prediction. Guideline-Based Recommendations
Diagnosis
Utilize gut microbial profiles as biomarkers for risk stratification in critically ill patients. Management
Implement microbiome-guided probiotics and prebiotics for personalized therapeutic strategies. Monitoring & Follow-up
Integrate microbiota profiles with clinical indicators for disease progression monitoring. Risks
Dysbiosis is associated with increased risk for various diseases, including infections and metabolic disorders. Patient & Prescribing Data
Patients with conditions influenced by gut microbiota, such as obesity, liver disease, and respiratory infections.
Postbiotic approaches and next-generation probiotics may offer therapeutic benefits.
Clinical Best Practices
Consider the role of gut microbiota in immune modulation when designing treatment plans. Employ systems biology approaches to develop precision diagnostic strategies. Related Resources & Content
